13 Results for "

CSF1R-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "CSF1R-IN-1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-101774
CAS No.: 2095849-04-8
Purity:  98.11%
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-1 is a CSF1R inhibitor with an with an IC50 of 0.5 nM.
loading...
    loading...
11
11 Publications Verification
Cat. No.: HY-50905
CAS No.: 405169-16-6
Synonyms: CHIR-258; TKI258
Target:  

FLT3 c-Kit FGFR VEGFR PDGFR c-Fms

Research Areas:  

Cancer

Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101768
CAS No.: 1802929-43-6
Purity:  99.78%
Target:  

FGFR c-Fms

Research Areas:  

Cancer

PRN1371 is a highly selective and potent FGFR1-4 and CSF1R inhibitor with IC50s of 0.6, 1.3, 4.1, 19.3 and 8.1 nM for FGFR1, FGFR2, FGFR3, FGFR4 and CSF1R, respectively .
loading...
    loading...
Cat. No.: HY-P990043
CAS No.: 2733621-19-5
Synonyms: VGL101

Research Areas:  

Inflammation/Immunology

Iluzanebart is a human monoclonal IgG1 antibody and is the agonist antibody for human TREM2 (hTREM2). Iluzanebart improves the survival and function of microglia by activating the TREM2 signaling pathway to compensate for the loss of CSF1R function. Iluzanebart can be used for research of adult-onset leukoencephalopathy associated with CSF1R (colony stimulating factor 1 receptor) (CSF1R-ALSP) .
loading...
    loading...
Cat. No.: HY-101774R
CAS No.: 2095849-04-8
Research Areas:  

Cancer

CSF1R-IN-1 (Standard) is the analytical standard of CSF1R-IN-1 (HY-101774). This product is intended for research and analytical applications. CSF1R-IN-1 is a CSF1R inhibitor with an with an IC50 of 0.5 nM.
loading...
    loading...
Cat. No.: HY-153012
CAS No.: 2394874-60-1
Target:  

TAM Receptor c-Fms

Research Areas:  

Cancer

Axl/Mer-IN-1 (Compound 1) is an Axl/Mer receptor tyrosine kinase (Axl/Mer RTK) and CSF1R inhibitor with Kds of <0.1 μM .
loading...
    loading...
Cat. No.: HY-50905R
CAS No.: 405169-16-6
Synonyms: CHIR-258 (Standard); TKI258 (Standard)
Research Areas:  

Cancer

Dovitinib (Standard) is the analytical standard of Dovitinib. This product is intended for research and analytical applications. Dovitinib (CHIR-258) is an orally active, potent multi-targeted tyrosine kinase (RTK) inhibitor with IC50s of 1, 2, 36, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, CSF-1R, FGFR1/FGFR3, VEGFR1/VEGFR2/VEGFR3 and PDGFRα/PDGFRβ, respectively. Dovitinib has potent antitumor activity .
loading...
    loading...
Cat. No.: HY-144041
CAS No.: 2716184-93-7
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-5 is a potent inhibitor of CSF1R. CSF-1R is expressed in macrophages, and the survival and differentiation of macrophages depends on the CSF-1/CSF-1R signaling pathway. CSF1R-IN-5 affects the exchange of inflammatory factors between TAMs and glioma cells. CSF1R-IN-5 has the potential for the research of cancer disease (extracted from patent WO2021197276A1, compound 11) .
loading...
    loading...
Cat. No.: HY-153277
CAS No.: 2394874-63-4
Target:  

TAM Receptor c-Fms

Research Areas:  

Neurological Disease

Axl/Mer/CSF1R-IN-2 (Comp 4) is a Axl, Mer and CSF1R inhibitor .
loading...
    loading...
Cat. No.: HY-157422
CAS No.: 1819989-27-9
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-19 is a potent inhibitor of CSF1R. CSF1R-IN-19 affects the exchange of inflammatory factors between TAMs and glioma cells. CSF1R-IN-19 has the potential for the research of cancer .
loading...
    loading...
Cat. No.: HY-144040
CAS No.: 2716185-86-1
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-4 is a potent inhibitor of CSF1R. CSF-1R is expressed in macrophages, and the survival and differentiation of macrophages depends on the CSF-1/CSF-1R signaling pathway. CSF1R-IN-4 affects the exchange of inflammatory factors between TAMs and glioma cells. CSF1R-IN-4 has the potential for the research of cancer disease (extracted from patent WO2021197276A1, compound 104) .
loading...
    loading...
Cat. No.: HY-144042
CAS No.: 2716184-87-9
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-6 is a potent inhibitor of CSF1R. CSF-1R is expressed in macrophages, and the survival and differentiation of macrophages depends on the CSF-1/CSF-1R signaling pathway. CSF1R-IN-6 affects the exchange of inflammatory factors between TAMs and glioma cells. CSF1R-IN-6 has the potential for the research of cancer disease (extracted from patent WO2021197276A1, compound 5) .
loading...
    loading...
Cat. No.: HY-101768R
CAS No.: 1802929-43-6
Research Areas:  

Cancer

PRN1371 (Standard) is the analytical standard of PRN1371 (HY-101768). This product is intended for research and analytical applications. PRN1371 is a highly selective and potent FGFR1-4 and CSF1R inhibitor with IC50s of 0.6, 1.3, 4.1, 19.3 and 8.1 nM for FGFR1, FGFR2, FGFR3, FGFR4 and CSF1R, respectively .
loading...
    loading...
  • 1